300272 开能健康
2025/09 - 九个月
人民幣(K¥)
与去年同期
比较
2024/12
人民幣(K¥)
2023/12
人民幣(K¥)
2022/12
人民幣(K¥)
2021/12
人民幣(K¥)
营业总收入1,355,6458.10%1,688,5011,671,6991,660,6421,511,487
减:营业总成本1,184,3576.53%1,520,9211,518,2421,533,8561,391,746
    其中:营业成本812,6418.48%1,030,0281,044,2881,096,8171,006,099
               财务费用16,79549.08%(4,063)8,13911,07821,060
               资产减值损失(1,292)-14.03%(7,057)(5,295)(23,594)(3,558)
公允价值变动收益(32)-1,164,618.48%(3,001)27,1227,362(2,430)
投资收益(33,885)129.49%(30,496)(22,461)(4,763)30,969
    其中:对联营企业和合营企业的投资收益(34,514)133.76%(30,635)(20,398)(6,638)(10,173)
营业利润144,0408.12%140,078161,807113,004152,186
利润总额143,1708.22%135,004158,805114,273145,493
减:所得税费用23,7184.73%21,5555,32815,23928,391
净利润119,4528.95%113,449153,47899,034117,103
减:非控股权益24,098-5.42%29,87321,0316,47212,243
股东净利润95,35313.29%83,576132,44792,562104,860

市场价值指针
每股收益 (元) *0.16712.52%0.1480.2360.1600.180
每股派息 (元) *0.1308.33%0.1600.1550.1000.100
每股净资产 (元) *2.35015.80%1.9782.1101.8892.083
审计意见 #--标准的无保留意见标准的无保留意见标准的无保留意见标准的无保留意见
回页顶
备注: *未调整数据
#只提供简体内容